Targeting the BCL2 Family: Advances and Challenges in BH3 Mimetic-Based Therapies.
Saved in:
| Title: | Targeting the BCL2 Family: Advances and Challenges in BH3 Mimetic-Based Therapies. |
|---|---|
| Authors: | Mukherjee N; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA., Sheetz J; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA., Shellman YG; Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.; Gates Institute, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.; Rocky Mountain Regional VA Medical Center, Aurora, CO 80045, USA. |
| Source: | International journal of molecular sciences [Int J Mol Sci] 2025 Oct 10; Vol. 26 (20). Date of Electronic Publication: 2025 Oct 10. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
